Pharma/Biotech - Page 1 | TalkMarkets
All Posts > Content under Pharma/Biotech
1 to 16 of 2383 Posts
1 2 3 ... 149
E Cassandra Is Silent
Article By: Vivian Lewis
Monday, February 19, 2018 1:16 AM EST
Friday, the lockstep move of bond and stock price broke down and stock prices rose solo. So maybe the stock selloff earlier this month is over. Or not.
In this article: AZSEY, NPSNY, RHHBY, TCEHY, HOLI, ZYME, BP, BUD, GRR, MXE, SQM, NILSY
Read
Valeant: Generic Syprine Is Here
Article By: Shock Exchange
Sunday, February 18, 2018 1:37 PM EST
Teva announced the launch of generic Syprine, which treats Wilson's disease. Valeant's Syprine and Cuprimine have combined quarterly revenue and of $38MM. Hits to Syprine and Cuprimine could hurt sentiment for Valeant.
In this article: VRX, TEVA
Read
Biotechs: Still Well Placed For More Gains
Article By: Tarun Chandra, CFA
Sunday, February 18, 2018 9:28 AM EST
The cold winds of February cut into the market as stocks found themselves going in an unaccustomed direction. Sliding like a toboggan, stocks last week experienced the sharpest correction in over 50 years, reaching the -10% mark within a week.
In this article: QQQ, DIA, IWM, SPY, IBB, XBI, SNY, CELG, GILD, JUNO, BIVV
Read
Warren Buffet Is Buying These 3 Stocks Right Now
Article By: TipRanks
Sunday, February 18, 2018 8:45 AM EST
Finding fresh investing inspiration can be a challenge, but if you examine billionaire Warren Buffett’s moves, you can find insights from one of the world’s most successful fund managers. Here are 3 stocks Buffett is buying and 3 he is selling...
In this article: BK, GM, IBM, SNY, AAPL, TEVA
Read
Week In Review: Harbin Pharma Invests $300 Million In US-based GNC; Forms China JV
Article By: ChinaBio® Today
Saturday, February 17, 2018 2:58 PM EST
Harbin Pharma will invest $300 million in GNC Holdings, a US nutritional supplement company, and form a JV for China manufacture and sales.
In this article: GNC, NBY, HCM
Read
Biotech Forum Daily Digest For February 16th
Article By: Bret Jensen
Friday, February 16, 2018 1:12 PM EST
The market has staged a huge bounce-back rally this week after two weeks of brutal declines. Teva Pharmaceuticals gets a boost from the Oracle of Omaha and Apricus Biosciences implodes after CRL from the FDA.
In this article: APRI, PCRX, TEVA, AMAG, ADVM, ATRS
Read
Catalyst Biosciences Announces Closing Of Public Offering Of Common Stock
Article By: NASDAQ GlobeNewswire
Thursday, February 15, 2018 5:36 PM EST
Catalyst Biosciences, today announced the closing of an underwritten public offering of 3,382,352 shares of its common stock, offered at a price of $34.00 per share to the public.
In this article: CBIO
Read
Biotech Deal Sparks Rally
Article By: Rod Raynovich
Wednesday, February 14, 2018 5:32 PM EST
Biopharmaceutical stocks rallied broadly with big large-cap movers: ALXN, AMGN, RHHBY; and mid-caps ALKS, BLUE, BPMC, NBIX and SGEN. Smaller caps were wildly up.
In this article: BMY, NAZ, RHHBY, ALXN, IBB, SGEN, ALKS, AMGN, NBIX, NKTR, FBT, XBI, BLUE, BPMC
Read
3 Canadian Licensed Producers With Impressive Earnings
Article By: Technical420
Wednesday, February 14, 2018 3:25 PM EST
We are now in earnings season for Canadian licensed marijuana producers and so far the numbers have been quite impressive.
In this article: OGRMF, ACBFF, MEDFF
Read
3 Public Cannabis Companies Pushing CBD For Pets
Article By: The Daily Marijuana Observer
Wednesday, February 14, 2018 2:37 PM EST
Humans with all kinds of ailments are already enjoying the therapeutic benefits of cannabis, but what about pets?
In this article: STNY, MJNA, VTNL Also: MCIG
Read
This Is Why You Need To Be Watching These 5 Canadian Cannabis Stocks
Article By: Technical420
Tuesday, February 13, 2018 2:38 PM EST
Canadian cannabis companies continue to be one of the most attractive opportunities as investors aim to capitalize on this burgeoning growth opportunity.
In this article: OGRMF, CNTTF, PHVAF, APHQF, ACBFF
Read
Catalyst Biosciences Announces The Pricing Of Public Offering Of Common Stock
Article By: NASDAQ GlobeNewswire
Tuesday, February 13, 2018 12:50 PM EST
Catalyst Biosciences, Inc. today announced the pricing of an underwritten public offering of 2,941,176 shares of its common stock, offered at a price of $34.00 per share to the public.
In this article: CBIO
Read
Pacific Biosciences Of California, Inc. Announces Proposed Public Offering Of Common Stock
Article By: NASDAQ GlobeNewswire
Monday, February 12, 2018 5:44 PM EST
Pacific Biosciences of California, Inc. today announced that it intends to offer and sell shares of its common stock in an underwritten public offering.
In this article: PACB
Read
Large Cap Biopharma Performance Update 2018
Article By: Rod Raynovich
Monday, February 12, 2018 9:59 AM EST
The FBT was the top performing ETF in 2018 YTD
In this article: BMY, MRK, AMGN, GILD, ABBV, BLUE, FMI, VRTX, FBIOX, CELG, FBT, IBB, XBI
Read
Three ETFs To Watch On Biotech Earnings
Article By: Zacks Investment Research
Monday, February 12, 2018 5:33 AM EST
The earnings season is off to a flying start, owing to a slew of upbeat economic data, strong corporate performance, and President Donald Trump's tax reform signed into law.
In this article: BIB, IBB, BBH Also: ALXN, AMGN, BIIB, GILD
Read
Week IReview: Tsinghua University Invests $276 Million ICambridge UK Biohub
Article By: ChinaBio® Today
Saturday, February 10, 2018 4:38 PM EST
Tsinghua University Holdings of Beijing will invest $276 million to build a new biohub in the UK's Cambridge Science Park. The biohub will be a joint venture between TUS and Trinity College, Cambridge, the owner of the park.
In this article: RNN, CELG, BGNE, PFE, ARQL, CBMG
Read
1 to 16 of 2383 Posts
1 2 3 ... 149